Compugroup Financial Statements From 2010 to 2025
| COP Stock | EUR 24.10 0.20 0.82% |
Check Compugroup Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compugroup Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Compugroup financial statements analysis is a perfect complement when working with Compugroup Medical Valuation or Volatility modules.
Compugroup |
Compugroup Medical SE Company Revenue Analysis
Compugroup Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Compugroup Medical Revenue | 1.03 B |
Most of Compugroup Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Compugroup Medical SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Compugroup Medical SE reported 1.03 B of revenue. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The revenue for all Germany stocks is notably lower than that of the firm.
Compugroup Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Compugroup Medical's current stock value. Our valuation model uses many indicators to compare Compugroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Compugroup Medical competition to find correlations between indicators driving Compugroup Medical's intrinsic value. More Info.Compugroup Medical SE is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for Compugroup Medical SE is about 932,263,654 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugroup Medical's earnings, one of the primary drivers of an investment's value.About Compugroup Medical Financial Statements
Compugroup Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Compugroup Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Compugroup Stock
Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.